Amid surging demand for syringes, a new investment supports long-term supply on the African continent

A Q+A with Surabhi Rajaram, Program Officer, Global Delivery Programs
A nurse prepares a syringe of the injectable polio vaccine at the Philippe Maguilen Senghor Hospital in Dakar, Senegal.
A nurse prepares a syringe of the injectable polio vaccine at the Philippe Maguilen Senghor Hospital in Dakar, Senegal. ©Gates Archive/Sylvain Cherkaoui

Read next

A miner receives a dose of the COVID-19 vaccine at Anglo American Platinum Ltd.'s Tumela mine in Amandelbult, South Africa. South African companies are playing a crucial role in helping the government counter the ravages of the pandemic among remote communities.

Global action to end the COVID-19 crisis

As the COVID-19 crisis continues, a well-coordinated global response is more important than ever. Drawing on insights from our broad array of partners, our foundation has identified a number of critical actions that can help stop the spread of the virus, help protect against future pandemics, and strengthen basic health systems around the world.
By Gargee Ghosh President, Global Policy & Advocacy, Bill & Melinda Gates Foundation
A laboratory at Afrigen Biologics & Vaccines in Cape Town, South Africa, which is partnering with the World Health Organization and the Biovac Institute to establish an mRNA technology transfer hub in Cape Town.

Geographically distributed manufacturing capacity is needed for improved global health security

Now is the time to support developing countries in building the infrastructure, skills, and systems they need to develop safe and affordable vaccines for diseases that mostly affect poorer nations.
By Anita Zaidi President, Gender Equality and Director, Vaccine Development and Surveillance, and Director, Enteric and Diarrheal Diseases programs, Bill & Melinda Gates Foundation
A drive-through coronavirus testing facility in Pretoria, South Africa.

As COVID-19 cases surge, African institutions lead response efforts

The world must act quickly to support African institutions in fighting the third wave of COVID-19 and bringing vaccines to the more than 98 percent of Africans who remain unvaccinated.
By Cheikh Oumar Seydi Director, Africa, Bill & Melinda Gates Foundation